Literature DB >> 21563229

Effects of splicing mutations on NF2-transcripts: transcript analysis and information theoretic predictions.

James R Ellis1, Bianca Heinrich, Victor-F Mautner, Lan Kluwe.   

Abstract

This study examined the effects of 22 putative splicing mutations in the NF2 gene by means of transcript analysis and information theory based prediction. Fourteen mutations were within the dinucleotide acceptor and donor regions, often referred to as (AG/GT) sequences. Six were outside these dinucleotide regions but within the more broadly defined splicing regions used in the information theory based model. Two others were in introns and outside the broadly defined regions. Transcript analysis revealed exon skipping or activation of one or more cryptic splicing sites for 17 mutations. No alterations were found for the two intronic mutations and for three mutations in the broadly defined splicing regions. Concordance and partial concordance between the calculated predictions and the results of transcript analysis were found for 14 and 6 mutations, respectively. For two mutations, the predicted alteration was not found in the transcripts. Our results demonstrate that the effects of splicing mutations in NF2 are often complex and that information theory based analysis is helpful in elucidating the consequences of these mutations.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21563229      PMCID: PMC3142993          DOI: 10.1002/gcc.20876

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  22 in total

Review 1.  The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2.

Authors:  D H Gutmann; A Aylsworth; J C Carey; B Korf; J Marks; R E Pyeritz; A Rubenstein; D Viskochil
Journal:  JAMA       Date:  1997-07-02       Impact factor: 56.272

2.  Sequence walkers: a graphical method to display how binding proteins interact with DNA or RNA sequences.

Authors:  T D Schneider
Journal:  Nucleic Acids Res       Date:  1997-11-01       Impact factor: 16.971

3.  Phenotypic variability associated with 14 splice-site mutations in the NF2 gene.

Authors:  L Kluwe; M MacCollin; M Tatagiba; S Thomas; W Hazim; W Haase; V F Mautner
Journal:  Am J Med Genet       Date:  1998-05-18

4.  Allelic expression of the NF2 gene in neurofibromatosis 2 and schwannomatosis.

Authors:  L B Jacoby; M MacCollin; D M Parry; L Kluwe; J Lynch; D Jones; J F Gusella
Journal:  Neurogenetics       Date:  1999-04       Impact factor: 2.660

5.  Exon skipping in IVD RNA processing in isovaleric acidemia caused by point mutations in the coding region of the IVD gene.

Authors:  J Vockley; P K Rogan; B D Anderson; J Willard; R S Seelan; D I Smith; W Liu
Journal:  Am J Hum Genet       Date:  2000-02       Impact factor: 11.025

6.  Information content of individual genetic sequences.

Authors:  T D Schneider
Journal:  J Theor Biol       Date:  1997-12-21       Impact factor: 2.691

7.  Information analysis of human splice site mutations.

Authors:  P K Rogan; B M Faux; T D Schneider
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

8.  Scanning and competition between AGs are involved in 3' splice site selection in mammalian introns.

Authors:  C W Smith; T T Chu; B Nadal-Ginard
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

9.  Alternative splicing of the NF2 gene and its mutation analysis of breast and colorectal cancers.

Authors:  H Arakawa; N Hayashi; H Nagase; M Ogawa; Y Nakamura
Journal:  Hum Mol Genet       Date:  1994-04       Impact factor: 6.150

10.  The neurofibromatosis 2 (NF2) tumor suppressor gene encodes multiple alternatively spliced transcripts.

Authors:  M J Pykett; M Murphy; P R Harnish; D L George
Journal:  Hum Mol Genet       Date:  1994-04       Impact factor: 6.150

View more
  4 in total

1.  In vitro antisense therapeutics for a deep intronic mutation causing Neurofibromatosis type 2.

Authors:  Elisabeth Castellanos; Imma Rosas; Ares Solanes; Isabel Bielsa; Conxi Lázaro; Cristina Carrato; Cristina Hostalot; Pepe Prades; Francesc Roca-Ribas; Ignacio Blanco; Eduard Serra
Journal:  Eur J Hum Genet       Date:  2012-11-28       Impact factor: 4.246

Review 2.  Interpretation of mRNA splicing mutations in genetic disease: review of the literature and guidelines for information-theoretical analysis.

Authors:  Natasha Caminsky; Eliseos J Mucaki; Peter K Rogan
Journal:  F1000Res       Date:  2014-11-18

3.  First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation.

Authors:  Ramita Dewan; Alexander Pemov; Amalia S Dutra; Evgenia D Pak; Nancy A Edwards; Abhik Ray-Chaudhury; Nancy F Hansen; Settara C Chandrasekharappa; James C Mullikin; Ashok R Asthagiri; John D Heiss; Douglas R Stewart; Anand V Germanwala
Journal:  BMC Cancer       Date:  2017-02-13       Impact factor: 4.430

4.  Identification of two novel insertion abnormal transcripts in two Chinese families affected with Dystrophinopathy.

Authors:  Ying Xu; Tingting Song; Yu Li; Fenfen Guo; Xin Jin; Lu Cheng; Jiao Zheng; Chunyan Li; Yingqi Zhang; Biliang Chen; Jianfang Zhang
Journal:  J Clin Lab Anal       Date:  2019-12-03       Impact factor: 2.352

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.